Finance

Lists
A:NYSE
Agilent Technologies Inc
$156.47
+0.08%
(+0.13) 1D
$160.00
+2.26% (+3.53)
After hours
Closed: Sep 18, 4:03:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for A...
Open
$156.00
High
$156.73
Low
$154.60
Mkt. cap
44.11B
Avg. vol.
2.14M
Volume
4.85M
Dividend
0.65%
Quarterly dividend
$0.25
Ex-dividend date
Jun 30, 2026
P/E ratio
30.84
52-wk high
$163.75
52-wk low
$108.35
EPS
$5.07
Beta
1.24
Shares outstanding
281.93M
No. of employees
18K
Open
$156.00
High
$156.73
Low
$154.60
Mkt. cap
44.11B
Avg. vol.
2.14M
Volume
4.85M
Dividend
0.65%
Quarterly dividend
$0.25
Ex-dividend date
Jun 30, 2026
P/E ratio
30.84
52-wk high
$163.75
52-wk low
$108.35
EPS
$5.07
Beta
1.24
Shares outstanding
281.93M
No. of employees
18K
News stories
From web sources and news partners
Profile
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government markets. Wikipedia
About Agilent Technologies Inc
CEOPadraig McDonnell
Employees18.2K
Founded1999
HeadquartersSanta Clara, California, United States
SectorHealth care
Websiteagilent.com
Analyst ratings
Based on 15 analysts giving stock ratings to A in the past 3 months
Strong buy
Buy
12
Hold
3
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for A in the last 3 months.
Highest
Current $156.47
$190.00 (+21.43%)
Average
$177.20 (+13.25%)
Lowest
$150.00 (-4.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Dunigan
Jefferies
Hold
Maintained
$181.00
+15.7%
09/17/2026
Blayne Curtis
Jefferies
Hold
Maintained
$155.00
-0.9%
09/11/2026
Unknown Analyst
UBS
Hold
Initiated
$165.00
+5.5%
09/08/2026
Doug Schenkel
UBS
Hold
Initiated
$165.00
+5.5%
09/09/2026
Eve Burstein
Bernstein
Buy
Maintained
$180.00
+15%
09/09/2026
Tycho Peterson
Jefferies
Hold
Maintained
$155.00
-0.9%
09/02/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Maintained
$175.00
+11.8%
09/01/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$180.00
+15%
08/30/2026
Evan Stampler
Wells Fargo
Buy
Maintained
$180.00
+15%
08/28/2026
Luke Sergott
Barclays
Buy
Maintained
$175.00
+11.8%
08/27/2026
David Westenberg
Piper Sandler
Hold
Reiterated
$150.00
-4.1%
08/27/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$172.00
+9.9%
08/27/2026
Dan Leonard
RBC Capital
Buy
Maintained
$185.00
+18.2%
08/26/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$180.00
+15%
08/27/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
$190.00
+21.4%
08/27/2026
Evie Koslosky
Goldman Sachs
Buy
Reiterated
$175.00
+11.8%
08/27/2026
Patrick B Donnelly
Citi
Buy
Maintained
$190.00
+21.4%
08/27/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
$180.00
+15%
08/27/2026
Sidharth Sahoo
HSBC
Buy
Maintained
$165.00
+5.5%
06/03/2026
Michael Polark
Wolfe Research
Hold
Initiated
$135.00
-13.7%
06/01/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
$160.00
+2.3%
05/28/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$156.00
-0.3%
05/26/2026
Jack Meehan
Nephron
Buy
Upgraded
$145.00
-7.3%
03/26/2026
Last report
Aug 26, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.62 / $1.49
+9.01%beat
Revenue / Est. (USD)
1.88B / 1.84B
+1.98%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
1.86B
1.80B
1.84B
1.88B
Cost of goods sold
893.00M
847.00M
842.00M
835.00M
Cost of revenue
893.00M
847.00M
842.00M
835.00M
Research and development expenses
117.00M
117.00M
126.00M
113.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
382.00M
423.00M
432.00M
450.00M
Operating expense
499.00M
540.00M
558.00M
563.00M
Total operating expenses
1.39B
1.39B
1.40B
1.40B
Operating income
469.00M
411.00M
435.00M
480.00M
Other non operating income
45.00M
3.00M
9.00M
3.00M
EBT including unusual items
442.00M
364.00M
408.00M
444.00M
EBT excluding unusual items
492.00M
404.00M
429.00M
469.00M
Income tax expense
8.00M
59.00M
69.00M
82.00M
Effective tax rate
1.81%
16.21%
16.91%
18.47%
Other operating expenses
-
-
-
-
Net income
434.00M
305.00M
339.00M
362.00M
Net profit margin
23.32%
16.96%
18.47%
19.28%
Earnings per share
1.59
1.36
1.49
1.62
Interest and investment income
17.00M
15.00M
13.00M
15.00M
Interest expense
-27.00M
-25.00M
-25.00M
-29.00M
Net interest expenses
-10.00M
-10.00M
-12.00M
-14.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
540.00M
478.00M
502.00M
546.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps